FDA-cleared profile

Adravision Perio

Adra Corporation · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Adravision Perio is semi-automated radiological image-processing software intended to aid dental professionals in measuring mesial and distal bone levels associated with each tooth from bitewing and periapical radiographs; it is labeled for U.S. patients age 22 years or older without remaining primary teeth.

Clinical role
Dental radiograph processing and measurements for professional assessment.
Images and patients
X-ray/Radiography · Teeth and mesial or distal alveolar bone levels
Key limitation
Keep in mind: Use only the exact labeled dental images, patient population, and workflow; output does not replace full patient evaluation or professional diagnosis.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Adravision Perio is semi-automated radiological image-processing software intended to aid dental professionals in measuring mesial and distal bone levels associated with each tooth from bitewing and periapical radiographs; it is labeled for U.S. patients age 22 years or older without remaining primary teeth.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Teeth and mesial or distal alveolar bone levels Input: Supported bitewing, periapical, CT, or MR data specified by the exact submission.
  • Who uses it?Intended users: Trained dentists, dental hygienists, dental radiologists, or other qualified dental professionals.
  • What does the software produce?Output: Dental measurements, models, or planning views for professional review.
  • What is its most important limitation?Key limitation: Use only the exact labeled dental images, patient population, and workflow; output does not replace full patient evaluation or professional diagnosis.

Clinical takeaway. Clinical role: Adravision Perio is semi-automated radiological image-processing software intended to aid dental professionals in measuring mesial and distal bone levels associated with each tooth from bitewing and periapical radiographs; it is labeled for U.S. patients age 22 years or older without remaining primary teeth.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports standalone bench studies on retrospectively collected radiographs (values for bitewing, then periapical): an OKS assessment of 340 radiographs against ground-truther key points (precision 91.0% and 84.8%, recall 94.0% and 89.3%) and a Length Measurement Assessment of 78 radiographs against consensus CAL measurements of three ground truthers (sensitivity 90.7 % and 92.5 %, specificity 94.3 % and 86.8 %, mean absolute error 0.434 mm and 0.504 mm). Results are as reported in the FDA submission, not independent validation.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Adravision Perio is semi-automated radiological image-processing software intended to aid dental professionals in measuring mesial and distal bone levels associated with each tooth from bitewing and periapical radiographs; it is labeled for U.S. patients age 22 years or older without remaining primary teeth.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Dental radiograph processing and measurements for professional assessment.
  • Exact FDA submission
  • Checked 2026-09-04
Required input
Supported bitewing, periapical, CT, or MR data specified by the exact submission.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
Dental measurements, models, or planning views for professional review.
  • Exact FDA submission
  • Checked 2026-09-04
Care setting
Dental or oral-health imaging and review environments.
  • Exact FDA submission
  • Checked 2026-09-04
Intended users
Trained dentists, dental hygienists, dental radiologists, or other qualified dental professionals.
  • Exact FDA submission
  • Checked 2026-09-04
Limitations
Use only the exact labeled dental images, patient population, and workflow; output does not replace full patient evaluation or professional diagnosis.
  • Exact FDA submission
  • Checked 2026-09-04
Evidence summary
The exact FDA document reports standalone bench studies on retrospectively collected radiographs (values for bitewing, then periapical): an OKS assessment of 340 radiographs against ground-truther key points (precision 91.0% and 84.8%, recall 94.0% and 89.3%) and a Length Measurement Assessment of 78 radiographs against consensus CAL measurements of three ground truthers (sensitivity 90.7 % and 92.5 %, specificity 94.3 % and 86.8 %, mean absolute error 0.434 mm and 0.504 mm). Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Adra completed standalone studies according to the predefined protocols to demonstrate the safety and effectiveness of the Adravision Perio device for its indications for use." … "In the OKS Assessment, Adravision Perio was evaluated with a total dataset of 340 dental radiographs (bitewing and periapical radiographs) and evaluated the precision and recall against the key points labeled by a ground truther". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports standalone bench studies on retrospectively collected radiographs (values for bitewing, then periapical): an OKS assessment of 340 radiographs against ground-truther key points (precision 91.0% and 84.8%, recall 94.0% and 89.3%) and a Length Measurement Assessment of 78 radiographs against consensus CAL measurements of three ground truthers (sensitivity 90.7 % and 92.5 %, specificity 94.3 % and 86.8 %, mean absolute error 0.434 mm and 0.504 mm). Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Adra completed standalone studies according to the predefined protocols to demonstrate the safety and effectiveness of the Adravision Perio device for its indications for use." … "In the OKS Assessment, Adravision Perio was evaluated with a total dataset of 340 dental radiographs (bitewing and periapical radiographs) and evaluated the precision and recall against the key points labeled by a ground truther". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
Standalone sensitivity for CAL length measurements against three-ground-truther consensus on 78 dental radiographs: 90.7 % (bitewing) and 92.5 % (periapical); no confidence intervals reported.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Adra completed standalone studies according to the predefined protocols to demonstrate the safety and effectiveness of the Adravision Perio device for its indications for use." … "In the Length Measurement Assessment, Adravision Perio was evaluated with a dataset of 78 dental radiographs and evaluated the sensitivity and specificity against the consensus CAL length measurements labeled by three (3) ground truthers within those radiographs.". Read from the exact FDA decision document on 2026-11-14; this is the submission-reported standalone result, not independent validation.

Reported specificity
Standalone specificity for CAL length measurements against three-ground-truther consensus on 78 dental radiographs: 94.3 % (bitewing) and 86.8 % (periapical); no confidence intervals reported.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Adra completed standalone studies according to the predefined protocols to demonstrate the safety and effectiveness of the Adravision Perio device for its indications for use." … "In the Length Measurement Assessment, Adravision Perio was evaluated with a dataset of 78 dental radiographs and evaluated the sensitivity and specificity against the consensus CAL length measurements labeled by three (3) ground truthers within those radiographs.". Read from the exact FDA decision document on 2026-11-14; this is the submission-reported standalone result, not independent validation.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

FDA submission-specific verification and validation evidence for K232440

  • DesignFDA 510(k) regulatory decision material and submission-specific verification or validation evidence for K232440; this is regulatory evidence, not an independent clinical effectiveness study.
  • PopulationThe labeled population, anatomy, images, and test materials described in the exact FDA decision material for K232440; a broader clinical population is not established here.
  • Scopeexact submission
  • Tested versionAdravision Perio (K232440)
  • IndependenceSponsor or vendor study

K232440

The exact FDA material is submission-specific and should not be generalized to other versions, enabled options, sites, protocols, or clinical outcomes.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Supported bitewing, periapical, CT, or MR data specified by the exact submission.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) decision material K232440: Adravision Perio

  2. Routing

    Source context, not route validation: The exact FDA package describes image input from the radiographic device or the practice management system, or by manual upload into the software, with DICOM, JPEG, TIFF, TIF and BMP among accepted image formats. Interface versions and local compatibility require confirmation.

    Scope: Exact FDA submission. Packet wording: "Both the proposed device and predicate support image input sources from the radiographic device and the practice management system. The proposed device additionally accepts manual upload of radiographs into the software" … "Both the proposed device and predicate support image formats of JPG, PNG, and JFIF. The proposed device additionally accepts DICOM, JPEG, TIFF, TIF and BMP image formats". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-11-14 · FDA 510(k) decision material K232440: Adravision Perio

  3. AI processing

    Source context, not route validation: The exact FDA package describes Adravision Perio as software that works on the Edge, Chrome, Firefox, Safari and Brave web browsers. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Both the proposed device and predicate device support common browsers of Edge, Chrome and Firefox. The proposed device additionally works on Safari and Brave.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA 510(k) decision material K232440: Adravision Perio

  4. Returned objects

    Source context, not route validation: Dental measurements, models, or planning views for professional review.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) decision material K232440: Adravision Perio

  5. Viewer/worklist/report

    Unresolved route: Dental measurements, models, or planning views for professional review.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) decision material K232440: Adravision Perio

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Adravision Perio as software that works on the Edge, Chrome, Firefox, Safari and Brave web browsers. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Both the proposed device and predicate device support common browsers of Edge, Chrome and Firefox. The proposed device additionally works on Safari and Brave.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact FDA package describes image input from the radiographic device or the practice management system, or by manual upload into the software, with DICOM, JPEG, TIFF, TIF and BMP among accepted image formats. Interface versions and local compatibility require confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Both the proposed device and predicate support image input sources from the radiographic device and the practice management system. The proposed device additionally accepts manual upload of radiographs into the software" … "Both the proposed device and predicate support image formats of JPG, PNG, and JFIF. The proposed device additionally accepts DICOM, JPEG, TIFF, TIF and BMP image formats". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Workflow role

Dental radiograph processing and measurements for professional assessment.

exact submission · checked 2026-09-04

Submission-anchored workflow summary, not a local acceptance or deployment result.

Input

Supported bitewing, periapical, CT, or MR data specified by the exact submission.

exact submission · checked 2026-09-04

Exact supported inputs and protocol limits must be confirmed from the complete labeling.

Output

Dental measurements, models, or planning views for professional review.

exact submission · checked 2026-09-04

Output review, editing, approval, export, and downstream use remain release- and site-specific.

Deployment evidence

Exact deployment topology and operational boundaries remain unestablished.

exact submission · checked 2026-09-04

Confirm hosting, PHI flow, retention, access, updates, downtime, and support obligations before procurement or clinical use.

Integration evidence

Exact local interfaces, identity matching, routing, display, reporting, and fallback behavior remain unestablished.

exact submission · checked 2026-09-04

Validate the local workflow against the exact release and enabled options.

Vendor family context

Current vendor material is product-family context for K232440 only; exact release, enabled options, deployment, security, interoperability, pricing, and local workflow require confirmation.

product family · checked 2026-09-04

Vendor material is not exact-release evidence unless that linkage is separately proven.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K232440
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Teeth and mesial or distal alveolar bone levels
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-12-05
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
31Fields reviewed
13Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor product page, implementation documentation, reimbursement policy, peer reviewed literature, clinical trial registry, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public exact-release price, license fee, subscription, contract, or implementation cost was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not applicable - checked 2026-09-04 - Not applicable

    CMS coverage-index context was checked, but no product-specific coverage or reimbursement determination is inferred.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-09-04 - Exact FDA submission

    Public sources reviewed here do not establish the complete exact-release security posture, including identity, audit, encryption, retention, remote access, vulnerability management, backup, or incident response.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA 510(k) decision material K232440: Adravision Perio

    U.S. Food and Drug Administration - Published 2023-12-05 - Accessed 2026-09-04

    Scope: identity, productIdentity, purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Adra dental imaging family context

    Adra Corporation - Accessed 2026-09-04

    Scope: productFamilyContext

Research history

  1. K232440 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K253192

DeepXray Spina

Alpha Intelligence Manifolds, Inc.

Authorized purpose: Opportunistic review of frontal lumbar-spine or KUB radiographs in adults aged 50 years and older to flag possible low bone mineral density at L1-L4 for clinician follow-up; a negative result does not rule out low BMD.

Modality
X-ray/Radiography
Anatomy
Spine/Bone Health
Decision
2026-06-10
FDA-cleared K260378

Rayvolve

AZmed

Authorized purpose: Rayvolve supports clinicians by identifying suspected fractures, joint effusions, and dislocations on labeled radiographic views; it does not replace clinician interpretation.

Modality
X-ray/Radiography
Anatomy
Musculoskeletal and chest/ribs radiographs across specified views
Decision
2026-05-12
FDA-cleared K252953

Velmeni for Dentists (V4D) Endo-Perio

Velmeni, Inc.

Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.

Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Decision
2026-05-11
FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history